This chartbook provides a snapshot of Medicaid pharmacy benefit use and reimbursement in 2003 and shows key trends from 1999 to 2003.

The Medicare Part D coverage gap has been associated with lower adherence and drug utilization and higher discontinuation. Because osteoporosis has a relatively high prevalence among Medicare-eligible postmenopausal women, we examined changes in utilization of osteoporosis medications during...

This chartbook, prepared for the Centers for Medicare & Medicaid Services, presents highlights and key comparisons from the state-by-state and national tables in the statistical compendium on Medicaid pharmacy benefit use and reimbursement in 2007.

This issue brief highlights a number of prescription drug issues that remain important for states after the shift of prescription drug coverage for Medicaid-Medicare dual eligibles to Medicare in 2006, including the use of antipsychotic drugs in nursing facilities and other settings. It focuses...

This chartbook highlights national and state-by-state data on Medicaid prescription drug use and expenditures for 2005 by beneficiary characteristics (age, sex, and race), basis of eligibility (children, adults, disabled, and aged), and type of drug (brand vs. generic, top 10 drug groups, top 7...

To compare healthcare costs associated with initiating treatment on escitalopram or an alternative selective serotonin reuptake inhibitor.

Launched in 2009, the Serious Mental Illness (SMI) Innovations project was a collaboration between physical and behavioral health managed care organizations and county behavioral health offices in Southeast and Southwest Pennsylvania to integrate physical and behavioral health care services for...